Clinical Trials for Recurrent Lung Non-Small Cell Carcinoma

Find clinical trials for recurrent lung non-small cell carcinoma. Discover research opportunities and treatment options in your area.

15 Active Trials Found

Showing 15 trials on this page

Page 1 of 1

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

NCT ID: NCT03191149

This clinical trial is studying the effectiveness of a medication called osimertinib in treating patients with advanced non-small cell lung cancer (NSCLC) that has a specific genetic change known a...

Recruiting

Phase: PHASE2 Type: interventional Locations: Boston, Massachusetts, United States, Buffalo, New York, United States +392 more

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

NCT ID: NCT05642572

This clinical trial, called the Lung-MAP trial, is studying how well certain targeted drugs work for patients with advanced non-small cell lung cancer (NSCLC) that has specific gene changes known a...

Recruiting

Phase: PHASE2 Type: interventional Locations: Denver, Colorado, United States, Cincinnati, Ohio, United States +71 more

PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer

NCT ID: NCT04151940

The clinical trial titled "PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer" is studying how imaging tests, specifically PET and C...

Recruiting

Phase: NA Type: interventional Locations: Seattle, Washington, United States

SX-682 With Pembrolizumab for the Treatment of Metastatic or Recurrent Stage IIIC or IV Non-Small Cell Lung Cancer

NCT ID: NCT05570825

This clinical trial is studying a combination of two medications, SX-682 and pembrolizumab, to see if they can effectively treat patients with advanced non-small cell lung cancer (NSCLC) that has s...

Recruiting

Phase: PHASE2 Type: interventional Locations: Seattle, Washington, United States

A Study of BDTX-4933 in Patients With KRAS, BRAF and Select RAS/MAPK Mutation-Positive Cancers

NCT ID: NCT05786924

This clinical trial is studying a new medication called BDTX-4933, which is being tested in patients with certain types of advanced cancers that have specific genetic mutations, like those found in...

Recruiting

Phase: PHASE1 Type: interventional Locations: Seattle, Washington, United States, New York, New York, United States +14 more

NBTXR3 and Radiation Therapy for the Treatment of Inoperable Recurrent Non-small Cell Lung Cancer

NCT ID: NCT04505267

This clinical trial is studying a new treatment option for patients with non-small cell lung cancer (NSCLC) that cannot be surgically removed and has returned after previous treatment. The trial is...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

NCT ID: NCT06616584

This clinical trial is looking at a new treatment option for people with advanced non-small cell lung cancer (NSCLC) that has either come back after treatment or has not improved with previous ther...

Recruiting

Phase: PHASE2 Type: interventional Locations: La Crosse, Wisconsin, United States, Effingham, Illinois, United States +78 more

Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer

NCT ID: NCT05098210

This clinical trial is exploring a new treatment option called a personalized neo-antigen peptide vaccine for patients with advanced melanoma (a type of skin cancer) or hormone receptor-positive br...

Recruiting

Phase: PHASE1 Type: interventional Locations: Seattle, Washington, United States

PBF-1129 and Nivolumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer

NCT ID: NCT05234307

This clinical trial is exploring a new treatment for patients with advanced non-small cell lung cancer (NSCLC) that has either returned after treatment or spread to other parts of the body. The stu...

Recruiting

Phase: PHASE1 Type: interventional Locations: Columbus, Ohio, United States

All-Trans Retinoic Acid (ATRA) and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer

NCT ID: NCT04919369

This clinical trial is studying a combination of two treatments—all-trans retinoic acid (ATRA) and atezolizumab—for patients with non-small cell lung cancer that has either come back or spread to o...

Recruiting

Phase: PHASE1 Type: interventional Locations: Columbus, Ohio, United States

Paclitaxel Therapeutic Drug Monitoring in Cancer Patients

NCT ID: NCT03987555

This clinical trial is studying how to better monitor the drug paclitaxel in patients with certain types of cancer, including breast, lung, cervical, ovarian, and vulvar cancers. Paclitaxel is a ch...

Recruiting

Type: observational Locations: Winston Salem, North Carolina, United States

Image-Guided, Intensity-Modulated Photon or Proton Beam Radiation Therapy in Treating Patients With Stage II-IIIB Non-small Cell Lung Cancer

NCT ID: NCT01629498

This clinical trial is studying a new way to deliver radiation therapy for patients with stage II to III non-small cell lung cancer, which is a type of lung cancer that is not suitable for surgery....

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

NCT ID: NCT06031688

This clinical trial is exploring a new treatment approach for advanced non-small cell lung cancer (NSCLC) that has a specific genetic change called the MET exon 14 skipping mutation. The trial is t...

Recruiting

Phase: PHASE2 Type: interventional Locations: Chicago, Illinois, United States, New Haven, Connecticut, United States +244 more

Vismodegib and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer

NCT ID: NCT06616623

This clinical trial is investigating the safety and effectiveness of a new treatment for patients with recurrent or metastatic non-small cell lung cancer (NSCLC), which is a type of lung cancer tha...

Recruiting

Phase: PHASE1 Type: interventional Locations: Columbus, Ohio, United States

Osimertinib, Cetuximab, and Tucatinib for the Treatment of EGFR-Mutant Stage IV or Recurrent Non-small Lung Cell Cancer

NCT ID: NCT06067776

This clinical trial is exploring the safety and effectiveness of a combination of three medications—osimertinib, cetuximab, and tucatinib—for treating patients with advanced or recurrent non-small ...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Sacramento, California, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions